Synonyms: CB-313 | Lysodren®
mitotane is an approved drug (FDA (1970), EMA (2004))
Compound class:
Synthetic organic
Comment: The molecular mechanism underlying mitotane's clinical effects is complex and poorly understood [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (1970) | EMA (2004) |
IUPAC Name ![]() |
1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene |
International Nonproprietary Names ![]() |
|
INN number | INN |
2597 | mitotane |
Synonyms ![]() |
CB-313 | Lysodren® |
Database Links ![]() |
|
CAS Registry No. | 53-19-0 |
ChEMBL Ligand | CHEMBL1670 |
DrugBank Ligand | DB00648 |
DrugCentral Ligand | 1820 |
GtoPdb PubChem SID | 178103539 |
PubChem CID | 4211 |
Search Google for chemical match using the InChIKey | JWBOIMRXGHLCPP-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | JWBOIMRXGHLCPP |
Search PubMed clinical trials | mitotane |
Search PubMed titles | mitotane |
Search PubMed titles/abstracts | mitotane |
UniChem Compound Search for chemical match using the InChIKey | JWBOIMRXGHLCPP-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JWBOIMRXGHLCPP-UHFFFAOYSA-N |
Wikipedia | Mitotane |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Mitotane (links to external site)
Cat. No. HY-13690
Mitotane (Standard) (links to external site)
Cat. No. HY-13690R |